Neuropsychology of migraine: present status and future directions

References

• Lipton RB, Stewart WF. Migraine in the Unites States: a review of epidemiology and heath care use. Neurology 43, S6–S10 (1993).
   PubMed Web of Science ®Google Scholar
• Lezak MD, Howieson DB, Loring DW. Neuropsychologic Assessment. Fourth Edition. Oxford University Press, NY, USA (2004).
   Google Scholar
• Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267, 64–69 (1992).
   PubMed Web of Science ®Google Scholar
• Marcus DA. Central nervous system abnormalities in migraine. Expert Opin. Pharmacother. 4, 1709–1715 (2003).
   PubMed Web of Science ®Google Scholar
• Maertens De Noorhout A, Timsit-Berthier M, Schoenen J. Contingent negative variation (CNV) in migraineurs before and during prophylactic treatment with β-blockers. Cephalalgia 5, 34–35 (1985).
   Google Scholar
• Schoenen J, Maertens De Noorhout A, Timsit-Berthier M, Timsit M. Contingent negative variation and efficacy of β-blocking agents in migraine. Cephalalgia 6, 229–233 (1986).
   PubMed Web of Science ®Google Scholar
• Kropp P, Gerber WD. Is increased amplitude of contingent negative variation in migraine due to cortical hyperactivity or to reduced habituation? Cephalalgia 13, 37–41 (1993).
   PubMed Web of Science ®Google Scholar
• Marcus DA, Soso MJ. Migraine and stripe induced visual discomfort. Arch. Neurol. 46, 1129–1132 (1990).
   Google Scholar
• Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structural diagnostic interview. Curr. Opin. Neurol. 16, 5–13 (2003).
   PubMed Web of Science ®Google Scholar
• De Tommaso M, Guido M, Libro G et al. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neurosci. Lett. 333, 29–32 (2002).
   PubMed Web of Science ®Google Scholar
• Burnstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol. 47, 614–624 (2000).
   PubMed Web of Science ®Google Scholar
• Burnstein R, Collins B, Bajwa A, Jakubowski M. Triptan therapy can abort migraine attacks if given before the establishment or in the absence of cutaneous allodynia and central sensitization: clinical and preclinical evidence. Headache 42, 390–391 (2002).
   Google Scholar
• Baum KA, Schulte C, Girke W, Reischies FM, Felix R. Incidental white matter foci on MRI in healthy subjects: evidence of subtle cognitive dysfunction. Neuroradiology 38, 755–760 (1996).
   PubMed Web of Science ®Google Scholar
• Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities. Arch. Neurol. 61, 1366–1368 (2004).
   PubMedGoogle Scholar
• Kruit MC, Van Buchem MA, Hofman PA et al. Migraine as a risk factor for subclinical brain lesions. JAMA 291, 427–434 (2004).
   PubMed Web of Science ®Google Scholar
• De Benedittis G, Lorenzetti A, Sina C, Bernasconi V. Magnetic resonance imaging in migraine and tension-type headache. Headache 35, 264–268 (1995).
   PubMed Web of Science ®Google Scholar
• Koeppen AH. The history of iron in the brain. J. Neurol. Sci. 134, 1–9 (1995).
   PubMed Web of Science ®Google Scholar
• Adams JD, Odunze IN. Oxygen free radicals and Parkinson’s disease. Free Rad. Biology Med. 10, 161–169 (1991).
   PubMed Web of Science ®Google Scholar
• Morris CM, Candy JM, Omar S, Bloxham CA, Edwardson JA. Transferrin receptors in the parkinsonian midbrain. Neuropathol. Appl. Neurobiol. 20, 468–472 (1994).
   PubMed Web of Science ®Google Scholar
• Halliwell B. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685–716 (2001).
   PubMed Web of Science ®Google Scholar
• Perry G, Sayre LM, Atwood CS et al. The role of iron and copper in the etiology of neurodegenerative disorders: therapeutic implications. CNS Drugs 16, 339–352 (2002).
   PubMed Web of Science ®Google Scholar
• Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41, 629–637 (2001).
   PubMed Web of Science ®Google Scholar
• Boyko OB, Burger PC, Shelburne JD, Ingram P. Non-heme mechanisms for Ti shortening: pathologic, CT, and MR elucidation. AJNR 13, 1439–1445 (1992).
   PubMed Web of Science ®Google Scholar
• Hooker WD, Raskin NH. Neuropsychologic alterations in classic and common migraine. Arch. Neurol. 43, 709–712 (1986).
   PubMedGoogle Scholar
• Heilman KM, Valenstein E. Clinical Neuropsychology. Fourth Edition. Oxford University Press, NY, USA (2003).
   Google Scholar
• Ardila A, Sanchez E. Neuropsychologic symptoms in migraine syndrome. Cephalalgia 8, 67–70 (1988).
   PubMed Web of Science ®Google Scholar
• Farmer K, Cady R, Bleiberg J, Reeves D. A pilot study to measure cognitive efficiency during migraine. Headache 40, 657–661 (2000).
   PubMed Web of Science ®Google Scholar
• Le Pira F, Zappala G, Giuffrida S et al. Memory disturbances in migraine with and without aura: a strategy problem? Cephalagia 20, 475–478 (2000).
   PubMed Web of Science ®Google Scholar
• Le Pira F, Lanaia F, Zappalà G et al. Relationship between clinical variables and cognitive performances in migraineurs with and without aura. Funct. Neurol. 19, 101–105 (2004).
   PubMed Web of Science ®Google Scholar
• Mulder EJCM, Linssesn WHJP, Passchier J, Orlebeke JF, de Geus EJC. Interictal and postictal cognitive changes in migraine. Cephalagia 19, 557–565 (1999).
   PubMed Web of Science ®Google Scholar
• Bell BD, Primeau M, Sweet JJ, Lofland KR. Neuropsychologic functioning in migraine headache, nonheadache chronic pain, and mild brain injury patients. Arch. Clin. Neuropsychol. 14, 389–399 (1999).
   PubMed Web of Science ®Google Scholar
• Burker E, Hannay JH, Halsey JH. Neuropsychologic functioning and personality characteristics of migrainous and nonmigrainous female college students. Neuropsychology 3, 61–73 (1989).
   Web of Science ®Google Scholar
• Jelicic M, Van Boxtel MJ, Houx PJ, Jooles J. Does migraine headache affect cognitive function in the elderly? Report from the Maastricht Aging Study. Headache 40, 715–719 (2000).
   PubMed Web of Science ®Google Scholar
• Leijdekkers MA, Passchier J, Goudswaard P et al. Migraine patients cognitively impaired? Headache 30, 352–358 (1990).
   PubMed Web of Science ®Google Scholar
• Haverkamp F, Honscheid A, Muller-Sinik K. Cognitive development in children with migraine and their healthy unaffected siblings. Headache 42, 776–779 (2002).
   PubMed Web of Science ®Google Scholar
• D’Andrae G, Nertempi P, Ferro Milone F, Joseph R, Canazi AR. Personality and memory in childhood migraine. Cephalagia 9, 25–28 (1989).
   PubMed Web of Science ®Google Scholar
• Zeitlin C, Oddy M. Cognitive impairment in patients with severe migraine. Br. J. Clin. Psychol. 23, 27–35 (1984).
   PubMed Web of Science ®Google Scholar
• Waldie KE, Hausmann M, Miline BJ, Poulton R. Migraine and cognitive function: a life-course study. Neurology 59, 904–908 (2002).
   PubMed Web of Science ®Google Scholar
• Martins IP, Cunha e Sa M. Loss of topographic memory and prosopagnosia during migraine aura. Cephalagia 19, 841–843 (1999).
   PubMed Web of Science ®Google Scholar
• Calandre EP, Bembibre J, Arnedo ML, Becerra D. Cognitive disturbances and regional cerebral blood flow abnormalities in migraine patients: their relationship with the clinical manifestations of the illness. Cephalalgia 22, 291–302 (2002).
   PubMed Web of Science ®Google Scholar
• Pavese N, Vista M, Ferroni L et al. Cognitive functions in migraineurs with or without white matter hyperintensities. J. Neurol. 242, 102 (1996).
   Google Scholar
• Meyer JS, Thornby J, Crawford K, Rauch AM. Reversible cognitive decline accompanies migraine and cluster headaches. Headache 40, 638–646 (2000).
   PubMed Web of Science ®Google Scholar
• Farmer K, Cady R, Reeves D. The effect of prodrome on cognitive efficiency. Headache 43, 518 (2003).
   Google Scholar
• Breteler MM, Van Duijn CM, Chandra V et al. Medical history and the risk of Alzheimer’s disease: a collaborative re-analysis of case-controlled studies EURODEM Risk Factors Research Group. Int. J. Epidemiol. 20(Suppl. 2), S36–S42 (1991).
   PubMed Web of Science ®Google Scholar
• Tyas SL, Manfreda J, Strain LA, Montgomery PR. Risk factors for Alzheimer’s disease: a population-based, longitudinal study in Manitoba, Canada. Int. J. Epidemiol. 30(3), 590–597 (2001).
   PubMed Web of Science ®Google Scholar
• Dodick DW, Martin V. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalagia 24, 417–424 (2004).
   PubMed Web of Science ®Google Scholar
• Evers S, Ruschenschmidt J, Frese A, Rahmann A, Husstedt IW. Impact of antimigraine compounds on cognitive processing: a placebo-controlled crossover study. Headache 43, 1102–1108 (2003).
   PubMed Web of Science ®Google Scholar
• Farmer K, Cady R, Bleiberg J et al. Sumatriptan nasal spray and cognitive function during migraine: results of an open-label study. Headache 41, 377–384 (2001).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch. Neurol. 61, 490–495 (2004).
   PubMed Web of Science ®Google Scholar
• Brandes JL, Saper JR, Diamond M et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 291, 965–973 (2004).
   PubMed Web of Science ®Google Scholar
• Young WB, Hopkins MM, Shechter AL, Silberstein SD. Topiramate: a case series study in migraine prophylaxis. Cephalalgia 22, 659–663 (2002).
   PubMed Web of Science ®Google Scholar
• Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche M. Effectiveness of topiramate in the prevention of childhood headaches. Headache 42, 810–888 (2002).
   PubMed Web of Science ®Google Scholar
• Krymchantowski A, Tavares C. Weight variations in patients receiving topiramate migraine prophylaxis in a tertiary care setting. Med. Gen. Med. 6, 48 (2004).
   PubMedGoogle Scholar
• Salinsky MC, Storzbach D, Spencer DC, Oken BS, Landry T, Dodrill CB. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 64(5), 792–798 (2005).
   PubMed Web of Science ®Google Scholar
• Martin R, Kuzniecky R, Ho S et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52(2), 321–327 (1999).
   PubMed Web of Science ®Google Scholar
• Lake AE, Rains JC, Penzien DB, Lipchik GL. Headache and psychiatric comorbidity: historical context, clinical implications, and research relevance. Headache (2005) (In Press).
   Google Scholar
• Penzien DB, Peatfield R, Lipchik GL. Headache in patients with co-morbid psychiatric disease. In: The Headaches. Second Edition. Olesen J, Goadsby P, Ramadan N, Tfelt-Hansen P, Welch K (Eds). Lippincott, Williams, and Wilkins, PA, USA (2005).
   Google Scholar
• Lipchik GL, Penzien DB. Psychiatric comorbidities in patients with headache. Sem. Pain Med. 2, 93–105 (2004).
   Google Scholar
• Scherer P, Bauer H, Baum K. Alternate finger tapping test in patients with migraine. Acta Neurol. Scand. 96, 392–396 (1997).
   PubMed Web of Science ®Google Scholar